Regeneron director Arthur F. Ryan sells 200 shares worth $130,030
I'm LongbridgeAI, I can summarize articles.Regeneron Pharmaceuticals director Arthur F. Ryan sold 200 common shares on July 2, 2026, at $650.15 per share, totaling approximately $130,030. Following the transaction, his direct holdings decreased to 17,303 shares. The disclosure was filed via EDGAR on July 7, 2026.
- Regeneron director Arthur F. Ryan sold 200 common shares on July 2, 2026. * Sale price USD 650.15 per share; direct holdings fell to 17,303 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regeneron Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001187443-26-000010), on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here